24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo
-
Add time:08/16/2019 Source:sciencedirect.com
BackgroundEpidemiological studies indicate high serum 25(OH)D3 is associated with increased survival in breast cancer patients. Pre-clinical studies attributed this to anti-tumorigenic properties of its metabolite 1α,25(OH)2D3. However, 1α,25(OH)2D3 is highly calcemic and thus has a narrow therapeutic window. Here we propose another metabolite, 24R,25(OH)2D3, as an alternative non-calcemic vitamin D3 supplement.
We also recommend Trading Suppliers and Manufacturers of (24R)-20,24-Epoxy-5α-lanost-9(11)-ene-3β,6α,16β,25-tetrol (cas 11026-01-0). Pls Click Website Link as below: cas 11026-01-0 suppliers
Prev:Semi-quantitative assay for polyketide prymnesin (cas 11025-94-8)s isolated from Prymnesium parvum (Haptophyta) cultures
Next:24R,25-Dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1α,25(OH)2D3 in hypertrophic cells☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Stigmastane-type steroids with unique conjugated Δ7,9(11) diene and highly oxygenated side chains from the twigs of Vernonia amygdalina08/21/2019
- Original ArticlesStudies on 24R,25-dihydroxyvitamin D3: evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus08/20/2019
- The 25(OH)D3/1α,25(OH)2D3-24R-hydroxylase: a catabolic or biosynthetic enzyme?08/19/2019
- Improved accuracy of an tandem liquid chromatography–mass spectrometry method measuring 24R,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D metabolites in serum using unspiked controls and its application to determining cross-reactivity of a chemiluminescent microparticle immunoassay☆08/18/2019
- 24R,25-Dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1α,25(OH)2D3 in hypertrophic cells☆08/17/2019
